Steven Cohen’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Sell
6,000
-9,700
-62% -$3.6M ﹤0.01% 2292
2026
Q1
$4.6M Sell
15,700
-18,100
-54% -$5.95M 0.01% 1761
2025
Q4
$11.8M Buy
33,800
+32,900
+3,656% +$11.1M 0.01% 1251
2025
Q3
$291K Sell
900
-2,700
-75% -$840K ﹤0.01% 2077
2025
Q2
$1.4M Sell
3,600
-1,000
-22% -$402K ﹤0.01% 1437
2025
Q1
$2M Sell
4,600
-3,700
-45% -$1.49M ﹤0.01% 1244
2024
Q4
$3.06M Sell
8,300
-900
-10% -$377K 0.01% 1095
2024
Q3
$4.78M Sell
9,200
-600
-6% -$321K 0.01% 889
2024
Q2
$5.31M Buy
9,800
+5,700
+139% +$3.01M 0.01% 814
2024
Q1
$2.13M Buy
4,100
+1,200
+41% +$597K 0.01% 1248
2023
Q4
$1.37M Hold
2,900
﹤0.01% 1312
2023
Q3
$1.26M Hold
2,900
﹤0.01% 1259
2023
Q2
$1.29M Sell
2,900
-3,000
-51% -$1.38M ﹤0.01% 1099
2023
Q1
$2.71M Buy
5,900
+4,900
+490% +$2.33M 0.01% 924
2022
Q4
$513K Hold
1,000
﹤0.01% 1146
2022
Q3
$454K Hold
1,000
﹤0.01% 1180
2022
Q2
$483K Buy
+1,000
New +$495K ﹤0.01% 1192

Other funds holding ELV

Steven Cohen's ELV Position: Q2 2026 in Review

Steven Cohen sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 59,341 shares — an estimated $22M sold.

Steven Cohen first reported a position in ELV in Q2 2014 and held it in 26 quarters. The position peaked at $173M in Q1 2019. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Steven Cohen reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 59,341 Elevance Health shares in Q2 2026, an estimated $22M.
  • Steven Cohen first reported a position in Elevance Health in Q2 2014 and held it in 26 quarters.
  • Steven Cohen's Elevance Health position peaked at $173M in Q1 2019.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.